Instruments

News (145)

Rithm Capital Corp. and Great Ajax Corp. Announce a Strategic Transaction BU
888 Holdings plc Announces Board and Committee Changes CI
Ellington Financial and Great Ajax Corp. Announce Definitive Merger Agreement BU
UK jobs and pay raise expectations of rate hike AN
Higher call after surprise fall in UK unemployment AN
National Health Investors : Q1 2023 Supplemental PU
National Health Investors : Q4 2022 Supplemental PU
Unilever hires dairyman as CEO; Wilson to depart L&G AN
Cardurion Pharmaceuticals Strengthens Leadership Team with Appointment of Elizabeth Radcliffe as Chief Financial Officer AQ
Fathom Events and Vertical Debut "Broadway Rising", Documentary Chronicles Broadway's Post-Pandemic Rebound Only In Theaters December 5 PR
National Health Investors : Q3 2022 Supplemental PU
Global Dividend Growth Split : Proxy Voting Record (July 1, 2021 to June 30, 2022) PU
Pryor Cashman Represents Luokung Technology Corp. In $8 Million Registered Direct Offering AQ
National Health Investors : Q2 2022 Supplemental PU
CYCLERION THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Symbotic LLC completed the acquisition of SVF Investment Corp. 3 from SVF Sponsor III (DE) LLC, SVFII SPAC Investment 3 (DE) LLC and others in a reverse merger transaction. CI
Megatrax Inks Multi-Year Licensing Agreement with Digitalage Inc. for Expanded Music Rights AQ
Horizon Acquisition II : Amendment to Annual Report (Form 10-K/A) PU
National Health Investors : Q4 2021 Supplemental PU
STXfilms: Adam Driver, Penélope Cruz and Shailene Woodley Join Michael Mann’s “Ferrari” BU
Symbotic LLC executed term sheet to acquire SVF Investment Corp. 3 from SVF Sponsor III (DE) LLC, SVFII SPAC Investment 3 (DE) LLC and others in a reverse merger transaction. CI
Winter reading: 10 books being adapted for film, TV AQ
Walt Disney : Disney+ Debuts First Looks, Exclusive Footage and New Trailers in Celebra… PU
Q3 2021 Supplemental PU
Cardurion Pharmaceuticals Announces Investment of up to $300 Million From Bain Capital BU
Luokung Technology : Pryor Cashman Represents Luokung Technology Corp. In Registered Direct Offering AQ
FOGHORN THERAPEUTICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
CYCLERION THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
ViacomCBS : New CBS Fall Schedule to Feature New Editions of “CSI,” “FBI” and “NCIS” BU
Timber Pharmaceuticals : Management's Discussion and Analysis of the Results of Operations AQ
National Health Investors : Q1 2021 Supplemental PU
Hodes Weill Hires Michael Mendelsohn As Senior Member of Global Distribution Team BU
Novartis : Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis PU
National Health Investors : Q4 2020 Supplemental PU
Cards Parent LP completed the acquisition of Collectors Universe, Inc. from Alta Fox Capital Management LLC and others. CI
Transcript : The Walt Disney Company - Analyst/Investor Day
Cards Parent LP entered into definitive agreement to acquire Collectors Universe, Inc. from Alta Fox Capital Management LLC and others for approximately $850 million. CI
The 2020 Annual Update of the Industry Economic Accounts Revised Statistics for 2015–2019 and the First Quarter of 2020 PU
The 2020 Annual Update of the National Income and Product Accounts PU
CYCLERION THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
Transcript : Cyclerion Therapeutics, Inc. - Shareholder/Analyst Call
Tech's First Big Plan to Tackle Covid-19 Stumbles : 'An App Is Not Going to Fix This.' DJ
Zeroing in on the Expected Returns of Anomalies PU
Cardurion Pharmaceuticals Announces Appointment of Peter Lawrence as President and Chief Executive Officer BU
Announcing the 3rd Annual Great Place to Work For All Leadership Awards BU
1234NextSee all

Companies (18)

ESTEE LAUDER 52 857 M $
Logo Estee Lauder

The Estée Lauder Companies Inc. is one of the 1st world cosmetics groups. Products are sold under brands (Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le La ...

ESTEE LAUDER 52 857 M $
Logo Estee Lauder

The Estée Lauder Companies Inc. is one of the 1st world cosmetics groups. Products are sold under brands (Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le La ...

CAPRI HOLDINGS LIMITED 4 143 M $
Logo Capri Holdings Limited

Capri Holdings Limited is a holding company, which owns brands that are designers, marketers, distributors and retailers of women’s and men’s accessories, footwear and ready-to-wear bearing the Versace, Jimmy Choo and Michael Kors tradenames and relat ...

PAGEGROUP PLC 1 750 M $
Logo PageGroup plc

PageGroup plc is a United Kingdom-based specialist recruitment consultancy company. It is engaged in providing recruitment services and career opportunities on a local, regional and global level. Its segments include EMEA, Asia Pacific, Americas and Unite ...

JS CORPORATION 174 M $
Logo JS Corporation

JS Corporation is a Korea-based company primarily engaged in the manufacture and distribution of fashion products. The Company provides handbags under the brands of BURBERRY, KATE SPADE, GUESS, MICHAEL KORS, DKNY, HENRI BENDEL, RALPH LAUREN and EVERLANE a ...

MYND LIFE SCIENCES INC. 1 M $
Logo MYND Life Sciences Inc.

MYND Life Sciences Inc. is a Canada-based medical biotech drug research and development company. The Company is focused on neuro-pharmaceutical drug development, diagnostics and vaccines. It is developing new biological entities (NBEs) and new chemical en ...

MICHAEL ANTHONY HOLDINGS, INC. 5 M $
Logo Michael Anthony Holdings, Inc.

Michael Anthony Jewelers is a multi-generational family owned and operated jewelry business. The Company offers a collection of diamond jewelries, which are imported from Italy, Germany, the United States, England, Australia and the Far East. The Company ...

3RD ROCK MULTIMEDIA LIMITED 17 M $
Logo 3rd Rock Multimedia Limited

3rd Rock Multimedia Limited is an India-based event management company. The Company conducts film promotions, international events, corporate events and cultural events. The Company's entertainment properties include 3rd Rock Fashion Fiesta and 3rd Rock C ...

BLOOMSBURY PUBLISHING PLC 560 M $
Logo Bloomsbury Publishing Plc

Bloomsbury Publishing Plc is an independent publishing house. The Company combines academic, educational, general fiction and non-fiction publishing for the general reader, children, teachers, students, researchers and professionals. It is engaged in offe ...

FOSSIL GROUP, INC. 42 M $
Logo Fossil Group, Inc.

Fossil Group, Inc. is a design, marketing and distribution company that specializes in consumer fashion accessories. The Company’s principal offerings include a line of men's and women's fashion traditional watches, smartwatches, jewelry, handbags, smal ...


12Next

Insiders

Picture Michael Mendelsohn
Michael Mendelsohn

Michael Mendelsohn was Vice President of Finance for DineEquity, Inc. Most recently, he was Chief Financial Officer and an Executive Vice President of Information Technology for Teleflora LLC.
Previously, he was Vice President of Business Operations, Finance and Accounting for the Walt Disney Internet Group.
He received a Bachelor of Arts degree in Economics from The Johns Hopkins University and holds an MBA.


Picture Michael Mendelsohn
Michael Mendelsohn

Michael Mendelsohn is currently a Managing Director at Star Mountain Fund Management LLC since 2023.
Prior to this, he worked as a Principal at Hodes Weill & Associates LP from 2021 to 2023.



Picture Michael Mendelsohn
Michael Mendelsohn

Dr. Michael E. Mendelsohn, MD, is an Independent Director at Cyclerion Therapeutics, Inc., an Independent Director at Foghorn Therapeutics, Inc., a Chairman at Cardurion Pharmaceuticals LLC, a Chief Medical & Scientific Officer at Takeda Pharmaceutical Co., Ltd. and a President at Mendelsohn Consulting Group LLC. He is on the Board of Directors at Cyclerion Therapeutics, Inc. and Foghorn Therapeutics, Inc. Dr. Mendelsohn was previously employed as a President & Chief Scientific Officer by Ironwood Pharmaceuticals, Inc., a Venture Partner by SV Life Sciences Managers LLP, an Independent Director by Regado Biosciences, Inc., a Senior VP & Global Head-Cardiovascular Research by Merck Research Laboratories Massachusetts LLC, an Executive Director-MCRI by Tufts Medical Center, Inc., and a Chief Scientific Officer by Tufts University School of Medicine. He received his undergraduate degree from Amherst College and a doctorate degree from Harvard Medical School.


No results for this search

  1. Stock Market
  2. Advanced search
  3. Michael Mendelsohn